Showing results (211-220 of 336) with videos related to

Sort By:
Pageof 34
The Journal of Thoracic and Cardiovascular Surgery|May 13, 2019
Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trialKenji Suzuki, Hisashi Saji, Keiju Aokage, et al.
Molecular Cancer Therapeutics|July 28, 2018
CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung CancerKenichi Suda, Isao Murakami, Hui Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2023
BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non-Small Cell Lung CancerSun Min Lim, Toshio Fujino, Chulwon Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2003
Expression of cancer/testis (CT) antigens in lung cancerKouhei Tajima, Yuichi Obata, Hiromi Tamaki, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancerKenji Tomizawa, Shigeki Shimizu, Shuta Ohara, et al.
Surgery Today|May 16, 2020
Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancerShuta Ohara, Kenichi Suda, Kenji Tomizawa, et al.
Cancer Science|February 3, 2007
Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32Tetsuo Taniguchi, Sivasundaram Karnan, Takayuki Fukui, et al.
Surgery Today|May 25, 2013
Paravertebral block via the surgical field versus epidural block for patients undergoing thoracotomy: a randomized clinical trialRei Kobayashi, Shoichi Mori, Kenji Wakai, et al.
Translational Lung Cancer Research|November 19, 2020
Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot studyShuta Ohara, Kenichi Suda, Kazuko Sakai, et al.
Cancer Science|May 31, 2016
Sensitivities to various epidermal growth factor receptor-tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor-tyrosine kinase inhibitor?Eri Banno, Yosuke Togashi, Yu Nakamura, et al.
Pageof 34